<code id='A7A781669B'></code><style id='A7A781669B'></style>
    • <acronym id='A7A781669B'></acronym>
      <center id='A7A781669B'><center id='A7A781669B'><tfoot id='A7A781669B'></tfoot></center><abbr id='A7A781669B'><dir id='A7A781669B'><tfoot id='A7A781669B'></tfoot><noframes id='A7A781669B'>

    • <optgroup id='A7A781669B'><strike id='A7A781669B'><sup id='A7A781669B'></sup></strike><code id='A7A781669B'></code></optgroup>
        1. <b id='A7A781669B'><label id='A7A781669B'><select id='A7A781669B'><dt id='A7A781669B'><span id='A7A781669B'></span></dt></select></label></b><u id='A7A781669B'></u>
          <i id='A7A781669B'><strike id='A7A781669B'><tt id='A7A781669B'><pre id='A7A781669B'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:leisure time    Page View:8854
          Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

          WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

          CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

          advertisement

          It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Paxlovid should be available without a positive Covid test
          Paxlovid should be available without a positive Covid test

          JoeRaedle/GettyImagesThepandemicisoverformostoftheworld.Butforthe2.7%ofadultsintheUnitedStateswhoare

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Senator probes 340B programs at Cleveland Clinic, Bon Secours

          Sen.BillCassidy(R-La.)StefaniReynolds/TheNewYorkTimesviaAPWASHINGTON—Thetop-rankingRepublicanontheSe